Ibritumomab, known as Zevalin, represents the novel form of specific radiotherapy employed to manage certain kinds of non-Hodgkin's lymphoma , particularly recurring lymphomas. This is an monoclonal https://nikolasihib346314.blog-gold.com/57821121/ibritumomab-a-thorough-dive-into-this-targeted-malignant-approach